- Home
- FSEA vs ICCC Comparison
FSEA vs ICCC Comparison
Compare FSEA & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ICCC
- Stock Information
- Founded
- FSEA 1890
- ICCC 1982
- Country
- FSEA United States
- ICCC United States
- Employees
- FSEA N/A
- ICCC N/A
- Industry
- FSEA Savings Institutions
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- ICCC Health Care
- Exchange
- FSEA Nasdaq
- ICCC Nasdaq
- Market Cap
- FSEA 47.0M
- ICCC 39.2M
- IPO Year
- FSEA N/A
- ICCC 1987
- Fundamental
- Price
- FSEA $10.82
- ICCC $5.02
- Analyst Decision
- FSEA
- ICCC
- Analyst Count
- FSEA 0
- ICCC 0
- Target Price
- FSEA N/A
- ICCC N/A
- AVG Volume (30 Days)
- FSEA 12.1K
- ICCC 4.1K
- Earning Date
- FSEA 03-28-2025
- ICCC 02-25-2025
- Dividend Yield
- FSEA N/A
- ICCC N/A
- EPS Growth
- FSEA N/A
- ICCC N/A
- EPS
- FSEA N/A
- ICCC N/A
- Revenue
- FSEA $11,390,000.00
- ICCC $23,838,001.00
- Revenue This Year
- FSEA N/A
- ICCC N/A
- Revenue Next Year
- FSEA N/A
- ICCC N/A
- P/E Ratio
- FSEA N/A
- ICCC N/A
- Revenue Growth
- FSEA N/A
- ICCC 46.37
- 52 Week Low
- FSEA $8.05
- ICCC $3.34
- 52 Week High
- FSEA $11.30
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- FSEA 67.92
- ICCC 47.31
- Support Level
- FSEA $10.31
- ICCC $4.84
- Resistance Level
- FSEA $10.97
- ICCC $5.25
- Average True Range (ATR)
- FSEA 0.24
- ICCC 0.27
- MACD
- FSEA 0.04
- ICCC -0.04
- Stochastic Oscillator
- FSEA 59.82
- ICCC 27.27
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.